New York, NYNCT05770570Now EnrollingIRB Ready

Overweight Clinical Trial in New York, NY

Access cutting-edge overweight treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access overweight specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related overweight treatment provided free

Apply for This New York Location

Check if you qualify for this overweight clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Overweight Study in New York

The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi and for-hire vehicle (FHV) drivers (Lyft, Uber, etc.). ROADMAP also utilizes an effectiveness- implementation hybrid type 1 design. Hybrid trials, which blend effectiveness and implementation studies, can lead to more rapid translational uptake and more effective implementation. Taxi and FHV drivers are a growing, multilingual, hard-to-reach, predominantly immigrant and minority essential worker population. There are over 750,000 licensed taxi and FHV drivers in in the U.S. and over 185,000 in New York City (NYC). They have higher rates of overweight/obese range body mass index (BMI) than New Yorkers in general (77% vs 56%) and have high rates of elevated waist circumference, sedentary behavior, poor diets, and health care services underutilization. ROADmAP will test 4 evidence- and theory-based (Social Cognitive Theory \[SCT\]) behavior change intervention components. We will use MOST to identify which of the 4 components contribute most significantly and cost-effectively to weight loss among NYC drivers recruited at workplace health fairs (HFs) and virtually. Objectives are to apply MOST to design an optimized version of a scalable, lifestyle intervention for taxi/FHV drivers, and then to conduct a mixed methods multistakeholder process evaluation to facilitate widespread intervention implementation.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

For COMIDA participants only:
Self-Identifies as Mexican American or Mexican
Seeking services at the VDS of the Mexican Consulate
Prefers to speak in Spanish
All adults at least 18 years of age
Screens as obese (an adult who has a Body Mass Index (BMI) 30 or higher) or overweight (an adult who has a BMI between 25 - 29.9)
Agrees to be audio recorded For SANOS focus group participants only:
Self-identifies as Hispanic/Latino;
Seeking services at VDS or VDS Mobile;
Prefers to speak in Spanish;
At least 18 years of age;
Screens as obese (BMI ≥ 30 kg/m\^2) or overweight (BMI of 25 - 29.9 kg/m\^2);
Agrees to be audio recorded For SANOS RCT participants only:
Self-identifies as Hispanic/Latino;
Seeking services at VDS or VDS Mobile;
Prefers to speak in Spanish;
At least 18 years of age;
Screens as obese (BMI ≥ 30 kg/m\^2) or overweight (BMI of 25 - 29.9 kg/m\^2);
Owns a cell phone capable of receiving text messages;
Agrees to be audio recorded For Family COMIDA participants only:
Self-Identifies as Hispanic/Latino
Seeking services at the VDS (or has used VDS services in the past) of the Mexican - Consulate or VDS Mobile
Prefers to speak in Spanish
At least 18 years of age
Has at least one child under age 18 living in the same household
Owns a cell phone capable of receiving text messages
Willing to receive text messages (3 texts per week for 3 months)
Owns an internet connected device (eg, cell phone, tablet, etc) capable of conducting teleconference calls (eg, Zoom) For ROADmAP RCT participants only:
At least 21 years of age
Full-time (drives at least 35 hours per week) licensed taxi/FHV driver
Driver for at least 6 months
Seeking Health Fairs (or has used Health Fairs services in the past)
Speaks English, French, Bengali, or Spanish
Screens a as obese (BMI ≥ 30 kg/m2 \[≥25 kg/m2 for South Asians\]) or overweight (BMI of 25 - 29.9 kg/m2 s \[23- 24.9 kg/m2 for South Asians\])
(BMI cut-offs are lower for South Asians, per WHO and American Diabetes Association recommendations)
Owns a cell phone capable of receiving text messages
Agrees to be audio-recorded For ROADmAP Phase 2 participants only:
At least 21 years of age
Driver who participated in ROADmAP RCT or manager at a taxi garage, Uber, Lyft or driver serving/union/organization
Agrees to be audio-recorded

Exclusion Criteria

For COMIDA participants only:
Will not be in the NYC area for the study duration (3-4 months) Is pregnant or might be pregnant
Lactating women
Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study)
Has dietary restrictions (i.e. liquid diet)
Does not have a phone that accepts text messages or unwilling to accept text messages
Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional"s judgment
Has another family member already enrolled in COMIDA (as determined by patient report) For SANOS focus group participants only:
Is pregnant or might be pregnant; lactating women;
Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate);
Has dietary restrictions (i.e. liquid diet);
Has a household member who has already participated (or agreed to participate); For SANOS RCT participants only:
Is pregnant or might be pregnant; lactating women; for the study duration (6 months)
Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate); restricting diet;
Currently has dietary restrictions (i.e. liquid diet);
Has a household member who has already participated (or agreed to participate);
Has already participated in the study
Will not be in the NY Metropolitan area for the study duration (6 months) Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services) For Family COMIDA participants only:
Is pregnant or might be pregnant; lactating women for the study duration (3 months)
Will not be in the NY Metropolitan area for the study duration (3 months) Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study)
Has dietary restrictions (i.e. liquid diet)
Has another family member who has already participated in COMIDA or SANOS
Has already participated in the study
Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services) For ROADmAP RCT participants only:
Is pregnant or might be pregnant; lactating women; for the study duration (12 months)
Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate) that may restrict diet
Currently has dietary restrictions (i.e. liquid diet)
Has a household member who has already participated (or agreed to participate)
Has already participated in the study
Will not be in the NY Metropolitan area for 6 months from study enrollment
Is currently taking Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity Saxenda, Victoza, Phentermine (Adipex, Lomaira), Extended-release Phentermine/Topiramate (Qsymia), Extended-release Naltrexone/Bupropion (Contrave), Plenity, Orlistat (Xenical) or Other GLP-1 receptor agonist, or any other drug to treat obesity or there is less than 7 weeks since last dosage.
Has undergone weight loss/bariatric surgery or is planning to undergo such surgery in the next 12 months.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT05770570) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Overweight Treatment Options in New York, NY

If you're searching for overweight treatment options in New York, NY, this clinical trial (NCT05770570) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced overweight specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all overweight clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in New York, NY

See all obesity clinical trials recruiting in New York — not just this study.

Browse Obesity Trials in New York →

Browse More Trials by Condition

Obesity TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY